Navigate Up
Sign In

Multiple Myelomas Clinic

The Coleman Foundation Comprehensive Multiple Myeloma Clinic provides patients with expert diagnostic, therapeutic and innovative management for these cancers. The clinic addresses the multiple organ systems that are affected with a team of specialists. 

Rush University Medical Center offers patients access to highly trained physicians, including a comprehensive clinic, that provide diagnostic and treatment services for multiple myeloma.​


John J. Maciejewski, MD, PhD, is currently the Interim Director of the Section of Bone Marrow Transplant and Cell Therapy at Rush, as well as the Clinical Program Director for Foundation for the Accreditation of Cellular Therapy (FACT). He staffs the outpatient bone marrow transplant (BMT) clinics as well as the inpatient bone marrow transplant rounds. His primary focus in stem cell transplantation has been in the fields of acute leukemia and multiple myeloma; he participates in both the Leukemia Comprehensive Care Clinic and the Multiple Myeloma Comprehensive Care Clinic. Dr. Maciejewski follows patients from diagnosis, through initial induction therapy, then throughout the stem cell transplantation process, and beyond. He also treats patients who suffer from graft-versus-host disease (GVHD), as well as patients who suffer from disease relapse after allogeneic stem cell transplantation. He is planning the inception of a BMT clinic devoted to the treatment of patients who have relapsed following allogeneic stem cell transplantation.

He is the principal investigator at Rush for several clinical trials targeting bone marrow transplant recipients and multiple myeloma patients. One of these clinical trials (BMT CTN 0702) is a study of single autologous transplant with or without consolidation therapy versus tandem autologous transplant with lenalidomide maintenance for multiple myeloma.

In addition, he has pledged to serve as a first-responder for the Midwestern United States in the Radiation Injury Treatment Network (RITN), which provides comprehensive evaluation and treatment for mass casualties with marrow toxic injuries from ionizing radiation exposure or other hazardous material.

Dr. Maciejewski holds memberships in the American Society for Blood and Marrow Transplantation, the American Society of Hematology, the American Society of Clinical Oncology, and in the Scientific Research Society, Sigma Xi. 

Agne Paner, MD, is an assistant professor of medicine at Rush University Medical Center, division of hematology. She subspecializes in benign hematology and multiple myeloma. Dr. Paner is the director of the Coleman Foundation Comprehensive Multiple Myeloma Clinic. She is a principal investigator of several clinical trials for multiple myeloma.

Dr. Paner is a diagnostic bone marrow biopsy director. She is involved in research of harvesting hematopoietic stem cells and utilizing them for treatment of cardiovascular disease.

Dr. Paner speaks fluent Lithuanian.

Parameswaran Venugopal, MD, is the Samuel Taylor III, MD, Professor of Oncology at Rush University Medical Center, where he is the Director of the Section of Hematology and Associate Director, DHOC. He received his medical degree from Trivandrum Medical College, University of Kerala, in India and then trained in Hematology/ Oncology at the Tata Memorial Cancer Center in Bombay. Dr. Venugopal earned a postgraduate Diploma in Clinical Hematology at the University of London, Royal Postgraduate Medical School, Hammersmith Hospital. Subsequently he completed residency and fellowship in Hematology-Oncology at Rush University Medical Center.

Dr. Venugopal is actively involved in clinical and laboratory research in leukemia and lymphoma. He has designed and conducted studies involving translational research combining monoclonal antibodies with cytotoxic and biologic agents in lymphoma, leukemia, and other hematological malignancies. The major focus of his research involves the development of novel methods of enhancing tumor response to biologic agents. In the laboratory, he has identified several cytokines that enhance the expression of tumor cell antigens, increasing their sensitivity to monoclonal antibodies. He has been an invited speaker at many medical institutions, both in the United States and abroad. He has authored or co-authored 91 full-length manuscripts, 7 book chapters, and over 240 abstracts.

Dr. Venugopal is an active member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. He has received awards from the American Society of Clinical Oncology/American Association for Cancer Research, the Cure For Lymphoma Foundation and the Berlex Oncology Foundation. He also serves on the Advisory Board of the Leukemia Society of  America.​​​

​​​​​​​​Services Provided
The Coleman Foundation Comprehensive Multiple Myeloma Clinic offers patients access to the following services:
  • Expert diagnosis
  • Advanced treatment options
  • Second opinion services
  • Complementary integrative cancer medicine
  • Supportive and educational services
Second Opinions
Rush welcomes patients seeking se​cond opinions​. If you have been diagnosed with multiple myeloma, you may want to get a second opinion to make sure that the diagnosis is accurate and that your treatment plan is the best one for you. 
Clinical Team
As part of the comprehensive clinic, consults are available with a number of specialists from the following departments, as applicable: orthopedic oncology, neurosurgery, nephrology, stem cell transplant, radiation oncology, general surgery, pain management and nutrition.
New Treatments and Clinical Trials
Because Rush is an academic medical center and our physicians are also researchers, we are able to quickly bring the latest therapies directly to our patients. We offer a number of clinical trials for both newly diagnosed and relapsed patients.

Accreditation and Recognition

Rush University Cancer Center
1725 W. Harrison St.
Professional Building I
Suite 1010
Chicago, IL 60612
Phone: (312) 563-2265
Fax: (312) 942-3192
Driving Directions

Rush Cancer Care in Oak Park
610 S. Maple Avenue
Rush Oak Park Professional Building
Suite 5400
1725 W. Harrison St.
Oak Park, IL 60304
Phone: (708) 660-6607
Fax: (708) 660-6602
Driving Directions

Rush Cancer Care in Lisle
430 Warrenville Road
Suite 200
1725 W. Harrison St.
Lisle, IL 60532
Phone: (630) 724-8700
Fax: (630) 724-8702
Driving Directions

Practice Resources

Forgot MyChart Username? Forgot Password?